Supportive Care

Conference Insider

Vemurafenib Beneficial for Nonmelanoma Cancers With BRAF V600 Mutations

09/19/2020

Study data presented by Pascale Tomasini, MD, and co-investigators at the 2020 ESMO Virtual Congress show that vemurafenib has an important role in the treatment of BRAF V600-mutated nonmelanoma cancers.

Study data presented by Pascale...

09/19/2020

Oncology

News

Adding Aspirin to Direct Oral Anticoagulant Therapy Does Not Improve Patient Outcomes

12/30/2019

Adding aspirin to direct oral anticoagulants in patients with VTE or non-valvular atrial fibrillation resulted in more bleeding events without significant improvement in thrombosis.

Adding aspirin to direct oral...

12/30/2019

Oncology

News

LMWID and Ferumoxytol Well-Tolerated as Treatment for Adult Iron Deficiency Anemia

12/30/2019

Treatment of iron deficiency with low molecular weight iron dextran (LMWID) or ferumoxytol was well-tolerated and led to minimal adverse events, study findings have shown.

Treatment of iron deficiency...

12/30/2019

Oncology

News

Perioperative Eltrombopag May Trump IVIG in Patients With ITP Undergoing Surgery

12/20/2019

Eltrombopag may be superior to IVIG for the achievement of platelet count targets in patients with ITP undergoing major and minor surgery, according data presented at ASH 2019.

Eltrombopag may be superior to...

12/20/2019

Oncology

News

Data Support Monitoring Patients After Treatment for Iron Deficiency Anemia

12/12/2019

According to data being presented at ASH 2019, patients with iron deficiency anemia should be monitored for serum phosphate after being treated with ferric carboxymaltose.

According to data being...

12/12/2019

Oncology

News

Bevacizumab Highly Effective for Chronic Bleeding in Hereditary Hemorrhagic Telangiectasia

12/06/2019

Findings from a retrospective study being presented at the 2019 ASH Annual Meeting support the use of bevacizumab to treat chronic bleeding and anemia in patients with hereditary hemorrhagic telangiectasia.

Findings from a retrospective...

12/06/2019

Oncology

News

Fostamatinib as Second-Line Therapy Yields Increased Response Rates in ITP

12/06/2019

Fostamatinib administered as second-line therapy in patients with immune thrombocytopenic purpura (ITP) and those with persistent ITP may lead to higher response rates than if the drug is used in later lines of therapy or for later-stage ITP.

Fostamatinib administered as...

12/06/2019

Oncology

News

Perioperative Iron Plus BOC Improves Outcomes in Patients Undergoing Gynecologic Procedures

12/06/2019

Study results being presented at ASH 2019 suggest that combining perioperative iron with blood optimization compound (BOC) can lead to improved patient outcomes.

Study results being presented at...

12/06/2019

Oncology